Company: LGN
Filing Date: 2025-02-14
Form Type: DRS
Source: 0000950123-25-002471
Chunk: 28

Company: Legence Corp.
Filing Date: 2025-02-14
Form: DRS
Chunk 28
---
                                  |                     |                       |   5,185 |   |     |      |  10,051 |   |     |      |     |   |     |           |     |   |
| Accelerated project sale(5)                                       |                     |                       |       — |   |     |      |  (7,401 | ) |     |      |     |   |     |           |     |   |
| Litigation settlements(6)                                         |                     |                       |   3,000 |   |     |      |       — |   |     |      |     |   |     |           |     |   |
| Adjusted EBITDA                                                   |                     |                     $ | 119,835 |   |     |    $ | 166,410 |   |     |    $ |     |   |     | $         |     |   |
| Adjusted EBITDA Margin                                            |                     |                       |     9.6 | % |     |      |    10.3 | % |     |      |     | % |     |           |     | % |

| (1) | Refer to Note 5 in the Notes to the Consolidated Financial Statements, for details on the nature of the 
 impairment.                                                                                             |

19

Confidential Treatment Requested by Legence Corp. Pursuant to 17 C.F.R. Section 200.83

| (2) | For the years ended December 31, 2023 and 2022, the figures include $3.8 and $5.6 million,                                                                                                                                                  
 respectively, of acquisition costs recorded in acquisition-related costs, and $1.6 and $1.0 million, respectively, of acquisition integration costs recorded in selling, general and administrative costs in the Consolidated Statements of 
 Operations.                                                                                                                                                                                                                                 |

| (3) | Represents consulting and initial upfront costs associated with implementing and optimizing certain enterprise 
 resource planning systems, including IFS, Onestream and Ceridian Dayforce.                                     |

| (4) | Represents (i) consulting costs associated with rebranding efforts in connection with our name change to                                                                                                                                             
 Legence that we do not expect to recur in the future, (ii) upfront consulting and out-of-pocket costs related to developing and launching the cross-selling                                                                                          
 framework amongst our brands, many of which were more recently acquired and integrated into the Legence brand, (iii) consulting and legal fees associated with education and marketing efforts for